Long-term therapy with agalsidase alfa for Fabry disease: safety and effects on renal function in a home infusion setting
Author:
Publisher
Oxford University Press (OUP)
Subject
Transplantation,Nephrology
Link
http://academic.oup.com/ndt/article-pdf/21/2/345/5234844/gfi152.pdf
Reference31 articles.
1. Brady R, Gal AE, Bradley RM et al. Enzymatic defect in Fabry's disease. N Engl J Med1967; 276: 1163–1167
2. Brady RO, Schiffmann R. Clinical features of and recent advances in therapy for Fabry disease. JAMA2000; 284: 2771–2775
3. Ferrans VJ, Hibbs RG, Burda CD. The heart in Fabry's disease. A histochemical and electron microscopic study. Am J Cardiol1969; 24: 95–110
4. Sessa A, Toson A, Nebuloni M et al. Renal ultrastructural findings in Anderson-Fabry disease. J Nephrol2002; 15: 109–112
5. Sheth KJ, Werlin SL, Freeman ME et al. Gastrointestinal structure and function in Fabry's disease. Am J Gastroenterol1981; 76: 246–251
Cited by 235 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Inflammation, Oxidative Stress, and Endothelial Dysfunction in the Pathogenesis of Vascular Damage: Unraveling Novel Cardiovascular Risk Factors in Fabry Disease;International Journal of Molecular Sciences;2024-07-29
2. Reduction in kidney function decline and risk of severe clinical events in agalsidase beta–treated Fabry disease patients: a matched analysis from the Fabry Registry;Clinical Kidney Journal;2024-07-02
3. Biomarkers in anderson-Fabry disease: what should we use in the clinical practice?;Rare Disease and Orphan Drugs Journal;2024-04-25
4. Long-term safety and efficacy of pegunigalsidase alfa: A multicenter 6-year study in adult patients with Fabry disease;Genetics in Medicine;2023-12
5. Safety and efficacy of pegunigalsidase alfa in patients with Fabry disease who were previously treated with agalsidase alfa: results from BRIDGE, a phase 3 open-label study;Orphanet Journal of Rare Diseases;2023-10-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3